Global Mobile and Wireless Backhaul (Microwave, Millimeter Wave, Sub-6 GHZ, Test and Measurement Equipment) Market 2013-2018)
M2 - Mon Apr 14, 3:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7wcp32/mobile_and) has announced the addition of the "Global Mobile and Wireless Backhaul (Microwave, Millimeter Wave, Sub-6 GHZ, Test and Measurement Equipment) Market 2013-2018)" report to their offering. The global market to grow from $13.11 billion in 2013 to $23.30 billion in 2018, at a Compound Annual Growth Rate (CAGR) of 12.2% Mobile and wireless backhaul refers to a communication network section which facilitates transportation of mobile data traffic. With increasing Long-Term Evolution (LTE) and small-cell deployments, availability of smart communication devices, and technological progress, the telecommunication industry is foreseeing extensive growth in mobile data traffic. In the present scenario, mobile and wireless backhaul networks are evolving from hauling voice-only traffic to voice and video traffic. This transition requires high-bandwidth capacity to accommodate such large data traffic along with maintaining the delivery of quality mobile services to the end customer. Mobile operators in the wireless industry are bound to boost their backhauling techniques and make huge investments in their networks to support profitability with performance. Also, in order to improve revenue growth, the operators need to uphold the networks compatible with 2G, 3G, High-Speed Packet Access (HSPA), Long-Term Evolution (LTE) technologies. The market is booming, and in the near future it will present momentous potential opportunity to various mobile operators, backhaul equipment vendors, and service providers. In this research report, the market is segmented into equipment and service segments, across various geographical regions such as North America (NA), Europe (EU), Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America (LA). Key players in this market include Cisco, Alcatel-Lucent, Huawei, Ericsson, Fujitsu, and ZTE among many other major vendors. This research report has been designed for backhaul vendors and mobile operators in the telecommunication industry to help them with better insights into market dynamics, competitive landscape, key market opportunities, and worldwide forecasts from 2013 to 2018. The report also focuses on global adoption trends, evolving technologies, and venture capital funding. Scope of the Report Equipment - Microwave equipment - Millimeter wave equipment - Sub-6 GHz equipment - Test and measurement equipment Services - Network services - System integration - Professional services Key Topics Covered: - Introduction - Executive Summary - Market Overview - Market Size And Forecast By Equipment - Market Size And Forecast By Services - Market Size And Forecast By Regions - Market Landscape - Company Profiles - Airspan Networks - Alcatel-Lucent - Alpha Omega Wireless - Blinq Networks - Bluwan - Bridgewave Comunications - Broadcom Corporation - Cambridge Broadband Network Ltd - Cisco - Dragonwave - Ericsson - Fastback Networks - Fujitsu - Huawei - Hughes - Intracom - Jdsu - Max4G - NEC - Nokia Siemens Networks - Orange Telecom - Positron Access - Sub10 Systems - Tarana Wireless - Telco Systems - Tellabs - Transmode - Vitesse Semiconductor - Vubiq - ZTE For more information visit http://www.researchandmarkets.com/research/7wcp32/mobile_and
Research and Markets: United Kingdom Nuclear Imaging Equipment Market Outlook to 2020
Business Wire - Wed Apr 09, 1:13PM CDT
Research and Markets (http://www.researchandmarkets.com/research/xxd5pd/united_kingdom) has announced the addition of the "United Kingdom Nuclear Imaging Equipment Market Outlook to 2020" report to their offering.
United Kingdom Nuclear Imaging Equipment Market Outlook to 2020
M2 - Wed Apr 09, 10:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/m32rj3/united_kingdom) has announced the addition of the "United Kingdom Nuclear Imaging Equipment Market Outlook to 2020" report to their offering. "United Kingdom Nuclear Imaging Equipment Market Outlook to 2020", provides key market data on the United Kingdom Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Nuclear Imaging Equipment market wherever available. Scope - Market size for Nuclear Imaging Equipment market categories - Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the United Kingdom Nuclear Imaging Equipment market. Key players covered include: - GE Healthcare - Philips Healthcare - Siemens Healthcare. Key Topics Covered: - Tables & Figures - Introduction - Nuclear Imaging Equipment Market, United Kingdom - Overview of Key Companies in United Kingdom, Nuclear Imaging Equipment Market - Nuclear Imaging Equipment Market Pipeline Products - Financial Deals Landscape - Recent Developments - Appendix For more information visit http://www.researchandmarkets.com/research/m3...ed_kingdom
Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI) Worth $5 Billion by 2017 - New Report by MarketsandMarket
PRWeb - Sat Apr 05, 9:31AM CDT
The "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) Technology and Market Analysis & Global Forecasts to 2017" ,analyzes amd studies the market impact of current and emerging breast imaging technologies that is having excellent growth potential in the coming next five years.
Medical Imaging Markets Report 2014: X-Ray, CT, MRI, Ultrasound, PET, SPECT & Others
M2 - Fri Apr 04, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3mp7zs/medical_imaging) has announced the addition of the "Medical Imaging Markets (X-Ray, CT, MRI, Ultrasound, PET, SPECT, Others)" report to their offering. This report, Medical Imaging Markets, analyzes the current and potential world markets for medical imaging systems, including x-ray, mammography, fluoroscopy, CT, MRI, Ultrasound, PET and SPECT, and fusion systems. This report generally forecasts future growth to 2018. Market segments covered include the world, US, European, BRIC, and Japanese markets. The evolution of medical imaging modalities - x-rays, mammographies, CT scans, MRIs, SPECT and PET scans - has had a major impact on the diagnosis and treatment of disease. Highly detailed imaging, especially at the molecular level, is enabling health care givers to visualize disease in new ways. For each of these modalities, the report provides current market size based on revenues to manufacturers of imaging systems used for molecular procedures, as well as forecasts of future revenues. This report also reviews the nature and direction of research and trends, and gives insight into some issues facing manufacturers and vendors. The report profiles several companies, including large companies that have made names for themselves in the field, as well as smaller firms with market niches. These companies are involved in developing and marketing these medical imaging systems. The following imaging markets are included in this report's analysis: - X-Ray - Digital X-Ray - Traditional X-Ray - Dental X-Ray - CT Scanners - MRI Systems - Ultrasound Systems - Mammography - Fluoroscopy - PET Systems - SPECT-Gamma Camera Systems - Fusion Systems - Molecular Imaging Key Topics Covered: - Executive Summary - Introduction - Trends And Issues - Market Developments - Imaging Markets - Key Corporate Profiles - Advanced Imaging Research Inc. - Agfa-Gevaert NV - Analogic Corp. - Carestream Health Inc. - Dilon Diagnostics - Esaote SpA - Fonar Corp. Gamma Medica - Fujifilm Medical Systems USA Inc. . - GE Healthcare - Hitachi Medical Systems America Inc. - Hologic Inc. - Mobisante Inc. - Philips Healthcare - Positron Corp - Samsung Electronics America - Shimadzu Corp. - Siemens Healthcare - Swissray Medical AG - Toshiba America Medical Systems - Varian Medical Systems - Zonare Medical Systems Inc. For more information visit http://www.researchandmarkets.com/research/3m...al_imaging
Research and Markets: United States Nuclear Imaging Equipment Market Outlook to 2020
Business Wire - Thu Mar 20, 1:29PM CDT
Research and Markets (http://www.researchandmarkets.com/research/czfwn8/united_states) has announced the addition of the "United States Nuclear Imaging Equipment Market Outlook to 2020" report to their offering.
United States Nuclear Imaging Equipment Market 2020 Forecasts in New Research Report at RnRMarketResearch.com
PRWeb - Thu Mar 20, 11:04AM CDT
This report provides key market data on the United States Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).
United States Nuclear Imaging Equipment Market Outlook to 2020
M2 - Thu Mar 20, 10:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jckjng/united_states) has announced the addition of the "United States Nuclear Imaging Equipment Market Outlook to 2020" report to their offering. "United States Nuclear Imaging Equipment Market Outlook to 2020", provides key market data on the United States Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Nuclear Imaging Equipment market wherever available. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Nuclear Imaging Equipment Market, United States 3.1 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2005-2012 3.2 Nuclear Imaging Equipment Market, United States, Revenue ($m), 2012-2020 3.3 Nuclear Imaging Equipment Market, United States, Volume (Units), 2005-2012 3.4 Nuclear Imaging Equipment Market, United States, Volume (Units), 2012-2020 3.5 Nuclear Imaging Equipment Market, United States, Average Price ($), 2005-2020 3.6 Nuclear Imaging Equipment Market, United States, Distribution Share by Revenue ($m), 2011-2012 3.7 Nuclear Imaging Equipment Market, United States, Company Share by Revenue ($m), 2011-2012 4 Overview of Key Companies in United States, Nuclear Imaging Equipment Market 5 Nuclear Imaging Equipment Market Pipeline Products 6 Financial Deals Landscape 6.1 Acquisition 6.2 Asset Transactions 6.3 Equity Offerings 6.4 Partnerships 7 Recent Developments 7.1 Corporate Communications 7.2 Financial Announcements 7.3 Government and Public Interest 7.4 Other Significant Developments 7.5 Strategy And Business Planning 8 Appendix Companies Mentioned Philips Healthcare GE Healthcare Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/jc...ted_states
New Partnership Agreement with the National Association of Attorneys General
M2 - Tue Feb 25, 6:25AM CST
Ambassador William R. Brownfield, Assistant Secretary of State for the Bureau of International Narcotics and Law Enforcement Affairs (INL), signed a partnership agreement today with Attorney General J.B. Van Hollen of Wisconsin, President of the National Association of Attorneys General (NAAG). Under this partnership, NAAG's National Attorneys General Training and Research Institute and INL will cooperate on advancing the development of rule-of-law institutions with partner countries around the world.
Concise Analysis of the International Radiopharmaceuticals Market
M2 - Fri Feb 14, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/5ltj8g/radiopharmaceutica) has announced the addition of the "Concise Analysis of the International Radiopharmaceuticals Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - France (2) - Germany (2) - The United Kingdom (4) - Italy (2) - Spain (1) - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5l...rmaceutica
Omeros Reports Additional Positive Phase 1 Clinical Data for OMS824 for the Treatment of Cognitive Disorders
PR Newswire - Tue Feb 11, 6:00AM CST
Omeros Corporation (NASDAQ: OMER) today announced additional positive data from its Phase 1 program for OMS824, the lead compound in Omeros' phosphodiesterase 10 (PDE10) program. This clinical trial evaluated the extent to which OMS824 binds to PDE10, an enzyme expressed in the region of the brain that has been linked to a wide range of diseases that affect cognition. In the latest cohort enrolled in this trial, OMS824 achieved a high of approximately 70--percent engagement at PDE10 without evidence of extrapyramidal symptoms (EPS). These data further support the potential of OMS824 to have a high therapeutic index in the treatment of patients with schizophrenia, Huntington's disease and other cognitive disorders. Omeros is completing a Phase 2a trial evaluating the drug in patients with schizophrenia and will start enrollment in a Phase 2 trial for Huntington's disease this quarter.
Cytogenetics Report - Technologies, Markets and Companies - 2014
M2 - Mon Feb 10, 10:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/m53hk3/cytogenetics) has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering. This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease. In the age of molecular biology, it is also referred to as molecular cytogenetics. Historical landmarks in the evolution of cytogenetics are reviewed since the first images of chromosomes were made in 1879. The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH. Molecular cytogenetics includes application of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection. Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies. FISH remains the single most important technology in cytogenetics. Several innovations are described of which the most important are single copy FISH, in vivo FISH (imaging of nucleic acids in living cells) and nanotechnology-based FISH. The unique character of peptide nucleic acid (PNA) allows these probes to hybridize to target nucleic acid molecules more rapidly and with higher affinity and specificity compared with DNA probes. PNA-FISH is more suited for rapid diagnosis of infections. RNA-FISH and locked nucleic acids (LNAs), are also described. Microarray/biochip-based technologies for cytogenetics promise to speed up detection of chromosome aberrations now examined by FISH. Other important genomic technologies are whole genome expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic applications. Optical Mapping can survey entire human genomes for insertions/deletions, which account for a significantly greater proportion of genetic variation between closely-related genomes as compared to single nucleotide polymorphisms (SNPs), and are a major cause of gene defects. Technologies encompassed within molecular imaging include optical imaging, magnetic resonance imaging (MRI) and nuclear medicine techniques. Positron emission tomography (PET) is the most sensitive and specific technique for imaging molecular pathways in vivo in humans. Cytogenetics can be refined by application of cytogenetics at single molecule level. Nanotechnology has facilitated the development of technology for single molecule imaging. Atomic force microscope (AFM) has become a well-established technique for imaging single biomolecules under physiological conditions. The scanning probe microscope (SPM) system is emerging as an increasingly important tool for non-intrusive interrogation of biomolecular systems in vitro and have been applied to improve FISH. Another example of application of nanobiotechnology is QD (quantum dot)-FISH probes, which can detect down to the single molecule level. There are connections between cytogenetics and biomarkers of genetic disorders as well as cancer. Biomarkers are very important for molecular diagnostics. Not only are molecular diagnostic technologies used for discovery of biomarkers, biomarkers are the basis of several diagnostics. As a means to understand pathomechanism of disease and as links between diagnostics and therapeutics, biomarkers are playing a role in development of personalized medicine. Application of cytogenetics extend beyond genetic disorder and cancer to diagnosis of several other diseases. Other important applications are drug discovery, and development of personalized medicine. The chapter on markets provides a global perspective of the cytogenetics business in the major markets: US, Western Europe (including France, Germany, Italy, Spain, and the UK), and Japan. The total figures for the market are also broken out according to the technologies and major disease areas in which they are applied. Markets figure are given for the year 2013 and estimates are made for the years 2018 and 2023. Advantages and limitations of various technologies have been pointed out throughout the report but this chapter includes SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis of some of the competing technologies including the following: conventional FISH, innovative FISH technologies, PCR-based assays, and single molecule imaging. Unfulfilled needs in cytogenetics market are depicted graphically. Among various technologies, FISH is most advanced and less opportunities for further development than single molecule detection, which is in infancy and has more future potential. Key Topics Covered: Executive Summary 1. Introduction 2. Technologies used for cytogenetics 3. Fluorescent In Situ Hybridization 4. Genomic Technologies relevant to Cytogenetics 5. Molecular Imaging & Single Molecular Detection 6. Role of Nanobiotechnology in Cytogenetics 7. Biomarkers and Cytogenetics 8. Applications of Cytogenetics 9. Cancer Cytogenetics 10. Cytogenetics Markets 11. Companies 12. References For more information visit http://www.researchandmarkets.com/research/m5...togenetics Source: Jain PharmaBiotech
2013 Report on the International Radiopharmaceuticals Market - Trends And Forecasts to 2018
M2 - Thu Jan 23, 3:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/fhpj27/radiopharmaceutica) has announced the addition of the "2013 Report on the International Radiopharmaceuticals Market - Trends And Forecasts to 2018" report to their offering. There is tremendous growth potential the radiopharmaceuticals market, especially in developing nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonal antibodies has opened new boulevards for the growth of the global radiopharmaceuticals market. Many radiopharmaceuticals use technetium-99m (Tc-99m) that has many useful properties of gamma-emitting tracer nuclide. This report analyses the global scenario of the radiopharmaceuticals market, discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data, and forecasts the radiopharmaceuticals market size, production forecasts along with key factors driving and restraining the market. The report also analyzes the radiopharmaceuticals market by generators and by further classifying them in terms of medical isotopes, their applications, end users and geographic distribution. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Global Radiopharmaceuticals Market Overview 4 Market Definition & Supply Chain Analysis 4.1 Market Definition 4.2 Radiopharmaceutical Production : A Global Perspective 4.3 Supply Chain Analysis 5 Global Radiopharmaceutical Generators Market 5.1 Overview 5.2 Mo-99/Tc-99m Generators 5.3 Sr-82/Rb-82 Generators 5.4 Ge-68/Ga-67,68 Generators 5.5 Sr-90/Y-90 Generators 5.6 W-188/Re-188 Generators 6 Global Radiopharmaceuticals Market, By End-User Groups 6.1 Overview 6.2 Hospitals and Medical Centers 6.3 Outpatient Diagnostic Centers 7 Global Radiopharmaceuticals Market, By Applications 8 Global Radiopharmaceuticals Market, By Geography 8.1 Overview 8.2 North America 8.3 Europe 8.4 Asia-Pacific (Apac) 8.5 Rest of the World 9 Market Share Analysis By Key Players 9.1 Radiopharmaceuticals Market 9.2 Generators Market 10 Recommendations 10.1 Identification and Elimination Of Barriers 10.2 Development of Total Solutions 10.3 Investing in Emerging Markets 10.4 Entering Monopoly Markets 11 Company Profiles Companies Mentioned: - Cardinal Health - Covidien - GE Healthcare - IBA Group - Lantheus Medical Imaging - Monrol Nuclear Products - NTP Radioisotopes - Nordion - Polatom - Positron Corporation - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/fh...rmaceutica
Global Medical Imaging Equipment Market Report 2013-2019: In-Depth X-ray, Ultrasound, CT, MRI and Nuclear Imaging Analysis
M2 - Wed Jan 15, 9:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/wn7p65/medical_imaging) has announced the addition of the "Global Medical Imaging Equipment Market Report 2013-2019" report to their offering. The report studies the global medical imaging equipment market based on the various types of equipments (product categories) as well as the different technologies used in each product segment. The five major categories of imaging equipments studied in this report include X-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging equipments. The market has also been segmented into four major geographies of the world, namely, North America, Europe, Asia-Pacific and Rest of the World. The market sizes and forecasts for each segment of the market have been calculated for the period 2011-2019 considering 2012 as the base year and have been expressed in the report in terms of USD million. The CAGR % for the forecast period 2013 to 2019 has also been provided for each market segment and sub-segment. A detailed qualitative analysis of the market dynamics, based on factors like drivers, restraints and opportunities has been presented in the market overview section of the report. This section also includes the Porter's five force analysis and market attractiveness analysis by geography for the global medical imaging equipment market. Market share analysis by key players operating in this market has been included in terms of percent share in the year 2012, in the competitive landscape section of the report. Scope of the Report Product Types X-ray Devices - Stationary X-ray Devices - Portable X-ray Devices Computed Tomography (CT) Scanners - Stationary CT - Portable/Mobile CT Ultrasound Systems - Trolley/Cart based ultrasound - Compact/Portable ultrasound Magnetic Resonance Imaging (MRI) Equipment - Closed MRI - Open MRI Nuclear Imaging Equipment - Single Photon Emission Computed Tomography (SPECT) Scanners - Positron Emission Tomography (PET) Scanners Technology X-ray Devices - Analog - Computed radiography (CR) - Digital radiography (DR) Computed Tomography (CT) Scanners - Low-slice scanners - Medium-slice scanners - High-slice scanners Ultrasound Systems - 2-D Imaging - 3-D & 4-D Imaging - Doppler - HIFU - Lithotripsy Magnetic Resonance Imaging (MRI) Equipment - High-field - Medium-field - Low-field Nuclear Imaging Equipment - Single Photon Emission Computed Tomography (SPECT) - Positron Emission Tomography (PET) Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Medical Imaging Equipment Market, by Product Type, 2011 - 2019 (USD Million) Chapter 5 Global Medical Imaging Equipment Market, by Technology, 2011 - 2019 (USD Million) Chapter 6 Global Medical Imaging Equipment Market, by Geography, 2011 - 2019 (USD Million) Chapter 7 Competitive Landscape Chapter 8 Recommendations Chapter 9 Company Profiles - Carestream Health, Inc - Fonar Corporation - Fujifilm Holdings Corporation - GE Healthcare Ltd - Genesis Medical Imaging, Inc - Hitachi Medical Corporation - Hologic, Inc - Philips Healthcare - Samsung Medison Co Ltd - Shimadzu Corporation - Siemens Healthcare - Toshiba America Medical Systems Inc For more information visit http://www.researchandmarkets.com/research/wn...al_imaging
Global Mobile and Wireless Backhaul Market Report 2013 - 2018
M2 - Mon Jan 13, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/89vfkq/mobile_and) has announced the addition of the "Global Mobile and Wireless Backhaul Market Report 2013 - 2018" report to their offering. Mobile and wireless backhaul refers to a section of mobile and wireless networks, which facilitates the transportation of mobile data traffic. With continuous increase in deployment of 4G/LTE, popularity of small cells, and availability and usage of smart devices, the mobile operators are facing challenges with traditional legacy backhaul networks. Up-gradation of wireless technology alone is not sufficient for delivering quality services to customers, so mobile operators have to go for evolved backhaul networks. In the present scenario, mobile and wireless backhaul networks are evolving from hauling voice-only traffic to voice and video traffic. This transition requires high-bandwidth capacity to accommodate such large data traffic along with maintaining the delivery of quality mobile services to the end customer. Mobile operators in the wireless industry are bound to boost their backhauling techniques and make huge investments in their networks to support profitability with performance. Also, in order to improve revenue growth, the operators need to uphold the networks compatible with 2G, 3G, High-Speed Packet Access (HSPA), Long-Term Evolution (LTE) technologies. The market is booming, and in the near future it will present momentous potential opportunity to various mobile operators, backhaul equipment vendors, and service providers. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Market Size And Forecast By Equipment 5 Market Size And Forecast By Services 6 Market Size And Forecast By Regions 7 Market Landscape 8 Company Profiles Companies Mentioned: - Airspan Networks - Alcatel-Lucent - Alpha Omega Wireless - BTI Systems - Blinq Networks - Bluwan - Bridgewave Comunications - Broadcom Corporation - Brocade - Cambridge Broadband Network Ltd - Cisco - Dragonwave - Ericsson - Fastback Networks - Fsona - Fujitsu - Huawei - Hughes - Intracom - Jdsu - Max4G - NEC - Nokia Siemens Networks - Orange Telecom - Positron Access - Radwin - Siklu - Sub10 Systems - Transmode - Vitesse Semiconductor - Vubiq - ZTE For more information visit http://www.researchandmarkets.com/research/89vfkq/mobile_and
Breast Imaging Technologies Market (Digital Mammography, Molecular Breast Imaging) worth $5 Billion - 2017
M2 - Mon Dec 16, 4:30AM CST
According to a new market research report "Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) - Technology and Market Analysis & Global Forecasts to 2017" , is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential in the coming five years. The technologies profiled in the report are segmented into Ionizing breast imaging modalities and Non-Ionizing breast imaging technologies on basis of radiation. Ionizing breast imaging modalities include Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI), Positron Emission Tomography (PET) and Breast Specific Gamma Imaging (BSGI). The various Non-ionizing modalities for breast screening covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.
GE Healthcare Delivers Innovative Technology to Advance Cancer Care
Business Wire - Wed Dec 04, 9:00AM CST
As part of its ongoing commitment to accelerating cancer innovation and assembling tools to fight the disease, GE Healthcare, a unit of General Electric Company (NYSE: GE), will highlight the benefits of the company's broad portfolio of advanced cancer treatment solutions at the 2013 Radiological Society of North America (#RSNA13) annual meeting. GE's innovations, including Positron Emission Tomography (PET), Molecular Breast Imaging (MBI) and Automated Whole Breast Ultrasound System (ABUS) diagnostic imaging procedures, provide clinicians with improved tools to better detect cancer and monitor therapy. These breakthrough offerings are in the spirit of GE Healthcare's $1 billion commitment to fight cancer.
2013 Report on the International Medical Imaging Market
M2 - Fri Nov 29, 6:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/c8285j/medical_imaging) has announced the addition of the "2013 Report on the International Medical Imaging Market" report to their offering. Picture archiving and communication systems (PACS) and contrast agents are the sub-segments in medical imaging market that have gained significant growth in recent years. As a result of these medical imaging advancements, the multi-slice systems are generating large volumes of data, and this creates demand for data storage, 3-D visualization and analysis. This research report also profiles the main companies involved in the international medical imaging market. In this section, each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Key Topics Covered: 1. Overview 1.1 Statement of This Report 1.2 Scope of This Report 1.3 Methodology 1.4 Executive Summary 2. Medical Imaging Technologies: An Overview 2.1 X-Ray 2.2 Computed Radiography 2.3 Digital Radiography 2.4 Fluoroscopy and C-Arms Systems 2.5 Mammography 2.6 Bone Densitometry Scanners 2.7 Computed Tomography 2.8 MRI Scanners 2.9 Ultrasound Scanners 2.10 Nuclear Imaging 2.11 Nuclear Medicine 3. Medical Indications for the Currently Available Imaging Modalities 3.1 Medical Imaging in Cancer Care 3.2 Global Incidence of Cardiovascular Diseases 3.3 Global Incidence of Neurological Disorders 3.4 Musculoskeletal Disorders 4. Medical Imaging: Market Analysis 5. Relative Use of Imaging Modalities in Future 6. Company Profiles Companies Mentioned - 3mensio Medical Imaging - Agfa Healthcare NV - B-K Medical ApS - Biosound Esaote, Inc. - Canon U.S.A., Inc. - GE Healthcare - Hologic, Inc. - Philips Healthcare - Positron Corporation - Siemens Healthcare - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/c8...al_imaging